Lonza Group AG Stock Swiss Exchange
Equities
CH0013841017
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
||
521.3 CHF | 0.00% |
Apr. 18 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... | |
Apr. 18 | Lonza Finance Launches EUR1 Billion 12-Year Euro Bond | DJ |
Sales 2024 * | 6.64B 7.27B | Sales 2025 * | 7.44B 8.15B | Capitalization | 37.7B 41.28B |
---|---|---|---|---|---|
Net income 2024 * | 904M 990M | Net income 2025 * | 1.11B 1.22B | EV / Sales 2024 * | 6 x |
Net Debt 2024 * | 2.18B 2.38B | Net Debt 2025 * | 2.47B 2.7B | EV / Sales 2025 * | 5.4 x |
P/E ratio 2024 * |
42.3
x | P/E ratio 2025 * |
33.9
x | Employees | - |
Yield 2024 * |
0.86% | Yield 2025 * |
0.99% | Free-Float | 95.87% |
Latest transcript on Lonza Group AG
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 17-04-24 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 21-11-30 |
Maria Nunez
COO | Chief Operating Officer | 55 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 14-04-15 |
Director/Board Member | 66 | 14-04-15 | |
Marion Helmes
BRD | Director/Board Member | 58 | 22-05-04 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B | |
-17.68% | 9.98B |